Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) [Phase 1]

View source ↗

Summary

Clinical trial update for BBT001 evaluating healthy volunteers and adults with moderate to severe atopic dermatitis in a Phase 1 study; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BBT001 (BBT001)

Snippet

Sponsor: Bambusa Therapeutics | Conditions: Atopic Dermatitis | Phase 1 | Status: RECRUITING